Literature DB >> 15138272

Histidine-rich glycoprotein binds to cell-surface heparan sulfate via its N-terminal domain following Zn2+ chelation.

Allison L Jones1, Mark D Hulett, Christopher R Parish.   

Abstract

Histidine-rich glycoprotein (HRG) is an alpha2-glycoprotein found in mammalian plasma at high concentrations (approximately 150 microg/ml) and is distinguished by its high content of histidine and proline. Structurally, HRG is a modular protein consisting of an N-terminal cystatin-like domain (N1N2), a central histidine-rich region (HRR) flanked by proline-rich sequences, and a C-terminal domain. HRG binds to cell surfaces and numerous ligands such as plasminogen, fibrinogen, thrombospondin, C1q, heparin, and IgG, suggesting that it may act as an adaptor protein either by targeting ligands to cell surfaces or by cross-linking soluble ligands. Despite the suggested functional importance of HRG, the cell-binding characteristics of the molecule are poorly defined. In this study, HRG was shown to bind to most cell lines in a Zn(2+)-dependent manner, but failed to interact with the Chinese hamster ovary cell line pgsA-745, which lacks cell-surface glycosaminoglycans (GAGs). Subsequent treatment of GAG-positive Chinese hamster ovary cells with mammalian heparanase or bacterial heparinase III, but not chondroitinase ABC, abolished HRG binding. Furthermore, blocking studies with various GAG species indicated that only heparin was a potent inhibitor of HRG binding. These data suggest that heparan sulfate is the predominate cell-surface ligand for HRG and that mammalian heparanase is a potential regulator of HRG binding. Using recombinant forms of full-length HRG and the N-terminal N1N2 domain, it was shown that the N1N2 domain bound specifically to immobilized heparin and cell-surface heparan sulfate. In contrast, synthetic peptides corresponding to the Zn(2+)-binding HRR of HRG did not interact with cells. Furthermore, the binding of full-length HRG, but not the N1N2 domain, was greatly potentiated by physiological concentrations of Zn2+. Based on these data, we propose that the N1N2 domain binds to cell-surface heparan sulfate and that the interaction of Zn2+ with the HRR can indirectly enhance cell-surface binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138272     DOI: 10.1074/jbc.M401996200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Histidine-Rich Glycoprotein Inhibits HIV-1 Infection in a pH-Dependent Manner.

Authors:  Juan Sabatté; Jorge Geffner; Ezequiel Dantas; Fernando Erra Díaz; Pehuén Pereyra Gerber; Augusto Varese; Diana Alicia Jerusalinsky; Alberto L Epstein; Hernán J García Rivello; Ana Del Valle Jaén; Julieta B Pandolfi; Ana Ceballos; Matias Ostrowski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Histidine-Rich Glycoprotein Stimulates Human Neutrophil Phagocytosis and Prolongs Survival through CLEC1A.

Authors:  Yohei Takahashi; Hidenori Wake; Masakiyo Sakaguchi; Yukinori Yoshii; Kiyoshi Teshigawara; Dengli Wang; Masahiro Nishibori
Journal:  J Immunol       Date:  2021-01-15       Impact factor: 5.422

3.  Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

Review 4.  Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

5.  Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase.

Authors:  Letizia Mattii; Francesco Bianchi; Alessandra Falleni; Sabina Frascarelli; Matilde Masini; Greta Alì; Grazia Chiellini; Antonietta R M Sabbatini
Journal:  J Histochem Cytochem       Date:  2019-12-27       Impact factor: 2.479

Review 6.  Heparanase: a target for drug discovery in cancer and inflammation.

Authors:  E A McKenzie
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

7.  Crystal structure of histidine-rich glycoprotein N2 domain reveals redox activity at an interdomain disulfide bridge: implications for angiogenic regulation.

Authors:  Omar Kassaar; Stephen A McMahon; Rory Thompson; Catherine H Botting; James H Naismith; Alan J Stewart
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

8.  Evidence that muscle cells do not express the histidine-rich glycoprotein associated with AMP deaminase but can internalise the plasma protein.

Authors:  A R M Sabbatini; L Mattii; B Battolla; E Polizzi; D Martini; M Ranieri-Raggi; A J G Moir; A Raggi
Journal:  Eur J Histochem       Date:  2011-02-25       Impact factor: 3.188

9.  Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin.

Authors:  O Kassaar; U Schwarz-Linek; C A Blindauer; A J Stewart
Journal:  J Thromb Haemost       Date:  2014-11-22       Impact factor: 5.824

10.  Conformational Modulation of Iduronic Acid-Containing Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound and Implications for Development of Antimetastatic Platinum Drugs.

Authors:  Anil K Gorle; Thomas Haselhorst; Samantha J Katner; Arun V Everest-Dass; James D Hampton; Erica J Peterson; Jennifer E Koblinski; Eriko Katsuta; Kazuaki Takabe; Mark von Itzstein; Susan J Berners-Price; Nicholas P Farrell
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-23       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.